ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Heart disease"

  • Abstract Number: 1204 • ACR Convergence 2022

    An Increased Risk of Heart Failure and Heart Failure-Related Death Persists in Rheumatoid Arthritis: A National, Matched Cohort Study from 2000 to 2019

    Tate Johnson1, Yangyuna Yang2, Punyasha Roul3, Windy Alonso2, Joshua Baker4, Brian Sauer5, Grant Cannon6, Ted Mikuls7 and Bryant England2, 1University of Nebraska Medical Center, Elkhorn, NE, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6Retired, Salt Lake City, UT, 7Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) predisposes patients to heart failure (HF), a leading cause of hospitalization in the US. While improvements in all-cause and cardiovascular (CVD)…
  • Abstract Number: 1471 • ACR Convergence 2022

    Trends and Predictors of Hospitalizations Due to Acute Myocardial Infarction in Systemic Lupus Erythematosus Patients

    Izza Bazigh1, Uzair Khan2, Achint Patel3, Aaparna Singh3, Neha Ghalib3, Ghazi Farman4, Salman Muddassir3, Farrukh Zaidi5, Sami Mughni3 and Adam Grunbaum6, 1HCA Florida Oak Hill Hospital, Spring Hill, FL, 2HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Odessa, FL, 3HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Spring Hill, FL, 4Rehman Medical College, Spring Hill, FL, 5HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Port Richey, FL, 6Gulf Coast Rheumatology, Trinity, FL

    Background/Purpose: Cardiovascular events occur more frequently and with earlier onset in patients with Systemic Lupus Erythematosus (SLE) compared with healthy individuals. Several studies have concluded…
  • Abstract Number: 1472 • ACR Convergence 2022

    Autoantibodies Against Tripartite-Motif 72 Protein (TRIM72) in Systemic Lupus Erythematosus Patients and in a Lupus Mouse Models with Myocarditis, Can Compromise Membrane Repair in Cardiomyocytes Potentially Contributing to Cardiovascular Disease Progression

    Kassidy Banford1, hannah Bulgart1, Shane Bruckner2, Stacy Ardoin3, Noah Weisleder2 and Wael Jarjour2, 1The Ohio State University Wexner Medical Center, Columbus, OH, 2The Ohio State University, Columbus, OH, 3The Ohio State College of Medicine, Columbus, OH

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease that typically manifests in multiple organs, with some of the most significant complications occurring in the…
  • Abstract Number: 1484 • ACR Convergence 2022

    Management of the Heightened Risk for Clinical Events from Atherosclerotic Cardiovascular Disease (ASCVD) in an Established Cohort of Lupus Erythematosus Patients

    Megan Zhao1, Kevin Williams2, Douglas Jacoby3, Rui Feng4 and Victoria Werth5, 1Perelman School of Medicine, Philadelphia, 2Temple University Hospital System, Philadelphia, 3University of Pennsylvania Health System, Philadelphia, 4University of Pennsylvania, Philadelphia, 5Philadelphia VAMC, Philadelphia, PA, USA and Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia

    Background/Purpose: Lupus erythematosus (LE) patients are at heightened risk of clinical events, chiefly heart attacks and strokes, caused by ASCVD. To address this problem, we…
  • Abstract Number: 1571 • ACR Convergence 2022

    Coronary Arteritis and Periarteritis Secondary to IgG4-related Disease in a Large, Single-center Cohort

    Guy Katz1, sandeep hedgire1, James Stone2, Sebastian Perez-Espina1, Ana Fernandes1, Cory Perugino1, Zachary Wallace1 and John Stone3, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Reading, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

    Background/Purpose: IgG4-related disease (IgG4-RD) is a systemic autoimmune fibroinflammatory disease capable of affecting most organ systems. Large-vessel vasculitis is a well-described manifestation of the disease.…
  • Abstract Number: 0284 • ACR Convergence 2022

    Compared Mortality and Cardiovascular Safety of JAK Inhibitors and Tocilizumab in Patients with RA : A Systematic Review and Network Meta-analysis

    Daniela Chicre1, Alisson Pugliesi1, Manoel Barros Bértolo1, Vani de Abreu Souza Filho1 and Luiz Sérgio F Carvalho2, 1Universidade Estadual de Campinas, Campinas, São Paulo, Brazil, 2Clarity: Inteligência em Saúde, Brasília, Brazil

    Background/Purpose: The ORAL-Surveillance trial showed important data on the comparative safety between Tofacitinib and TNF inhibitors (TNFi) in the treatment of RA, leading to safety…
  • Abstract Number: 1580 • ACR Convergence 2022

    Poor Serum Urate Control Is a Driver of Excess Cardiovascular Risk in Patients with Gout

    Tate Johnson1, Lindsay Helget2, Harlan Sayles2, Punyasha Roul3, James O'Dell2, Ted Mikuls4 and Bryant England2, 1University of Nebraska Medical Center, Elkhorn, NE, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Gout patients suffer from an increased burden of cardiovascular disease (CVD). It remains unclear whether this risk is related to an excess of CVD…
  • Abstract Number: 0345 • ACR Convergence 2022

    Association Between Cumulated Hydroxychloroquine in Systemic Lupus Erythematosus and Development of Cardiac Conduction Alterations: A Multiple Logistic Regression Analysis

    Alba Herrero-Morant1, Jon Zubiaur-Zamacola2, Adrián Margarida-De Castro2, Raquel Pérez-Barquín2, Miguel Ángel González-Gay3 and Ricardo Blanco4, 1Hospital Universitario Marqués de Valdecilla, Ontinyent, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Hydroxychloroquine (HCQ) is a widely used drug in Systemic Lupus Erythematosus (SLE). It may cause cardiac alterations which includes short term arrhythmic events (via…
  • Abstract Number: 1596 • ACR Convergence 2022

    The Role of Coronary Calcium Screening in Patients with Lupus Who Appear to Be at Low Cardiovascular Risk

    Sarah Stoots1, Joshua Baker1 and Joan Von Feldt2, 1University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Wilmington, DE

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at elevated cardiovascular risk. However, common risk calculators such as the atherosclerotic cardiovascular disease (ASCVD) risk estimator…
  • Abstract Number: 0679 • ACR Convergence 2022

    Outcomes of Antiphospholipid Antibody Syndrome and Acute Coronary Syndrome: Analysis of National Inpatient Sample 

    Faria Sami, Dennis Kumi and Shilpa Arora, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose: Antiphospholipid antibody syndrome (APLS) is strongly associated with the risk of cardiovascular events including acute coronary syndrome (ACS). However, there is limited data on…
  • Abstract Number: 1623 • ACR Convergence 2022

    Combined Single-Cell, Bulk RNA Sequencing and Proteomics Analysis Reveals New Candidate Targets Involved in Myocardial Fibrogenesis

    Ievgeniia Kocherova1, Elena Pachera2, Daria Nurzynska3, Franca Di Meglio3, Oliver Distler4, Przemysław Błyszczuk2 and Gabriela Kania2, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Schlieren, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 3Department of Public Health, University of Naples "Federico II", Naples, Italy, 4Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland

    Background/Purpose: Inflammatory dilated cardiomyopathy (iDCM) often leads to heart failure (HF), which is the main cause of cardiac mortality in patients with systemic autoimmune diseases.…
  • Abstract Number: 0741 • ACR Convergence 2022

    Prescribing Patterns of SGLT2 Inhibitors for Patients with Autoimmune Rheumatic Disease

    Emily G Oakes1, Jack Ellrodt1, May Choi2, Hongshu Guan1 and Karen Costenbader1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada

    Background/Purpose: Sodium-glucose co-transporter 2 inhibitors (SGLT2i, dapagliflozin, canagliflozin, and empagliflozin) are a class of oral hypoglycemic medication for management of Type II diabetes mellitus (T2D),…
  • Abstract Number: 1789 • ACR Convergence 2022

    Gout in Heart Failure Patients with Left Ventricular Assist Device Therapy in a Tertiary Academic Hospital

    Aakriti Arora1, Lakshmi Jayaram2, TEFERA ESHETU3 and FLORINA CONSTANTINESCU3, 1MedStar Washington Hospital Center, Georgetown University, Washington, DC, 2McGaw Medical Center, Northwestern University, Chicago, IL, 3MedStar Washington Hospital Center, Washington, DC

    Background/Purpose: Gout is one of the most common inflammatory joint diseases and is a disabling complication in patients with heart failure. Patients with gout and…
  • Abstract Number: 0805 • ACR Convergence 2022

    Rheumatic Fever and Streptococcal Cutaneous Infection: A Case-control Study in the Loyalty Islands, New Caledonia

    Quentin AMIC-DESVAUD1, Olivier MAILLARD2, Sylvia IACOBELLI3, Thomas BARDIN4 and Yves-Marie DUCROT5, 1Province des îles Loyauté, Lifou, New Caledonia, 2Centre Hospitalier Universitaire de la Reunion, Saint-Denis, France, 3Centre Hospitalier Universitaire, Saint Dénis de la Réunion, France, 4Université de Paris, Paris, France, 5Province des îles Loyauté, We, Lifou Island, New Caledonia

    Background/Purpose: Acute Rheumatic Fever (ARF) and Rheumatic Heart Disease (RHD) remain major public health problems in the South Pacific. Triggering by group A beta hemolytic…
  • Abstract Number: 1815 • ACR Convergence 2022

    Consistent Colchicine Use Is Associated with Decreased Major Adverse Cardiovascular Events in Patients with Gout and Established Cardiovascular Disease

    Gary Ho1, Michael Toprover2, Daria Crittenden3, binita Shah4 and Michael Pillinger5, 1New York University Grossman School of Medicine, VA New York Harbor Health Care System, Brooklyn, NY, 2Division of Rheumatology, New York University Grossman School of Medicine and Rheumatology Section, New York Harbor Health Care System, New York Campus of the U.S. Department of Veterans Affairs, New York, NY, 3CymaBay Therapeutics, New York University Grossman School of Medicine, Newark, CA, 4New York University Grossman School of Medicine, VA New York Harbor Health Care System, New York, NY, 5NYU Grossman School of Medicine, New York, NY

    Background/Purpose: Patients with gout are more likely than those without to have traditional risk factors for cardiovascular (CV) disease. Furthermore, the chronic, low-level inflammation experienced…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology